Cytosorbents Corp expected to post a loss of 11 cents a share - Earnings Preview

Cytosorbents

29/07/2023 01:31

* Cytosorbents Corp  CTSO.OQ   CTSO.O  is expected to show a
rise
in quarterly revenue when it reports  results on August 1. 
    * The Princeton New Jersey-based  company is expected to
report  a
29.8% increase in revenue to $11.026 million from $8.5 million a
year ago, according to the mean estimate from 4 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Cytosorbents Corp
is for
a loss of 11 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for
Cytosorbents Corp
is $6.5​, above​ its last closing price of $3.72. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.13       -0.13      -0.17     Missed  -34.2
 Dec. 31 2023  -0.18       -0.17      -0.02     Beat    88.1
 Sep. 30 2022  -0.16       -0.16      -0.28     Missed  -70.7​
 Jun. 30 2022  -0.14       -0.13      -0.25     Missed  -86.9
 ​​Mar.        -0.12       -0.12      -0.21     Missed  -71.4
 31 2022                                                
 Dec. 31 2021  -0.17       -0.13      -0.21     Missed  -58.6​
 Sep. 30 2021  -0.15       -0.12      -0.15     Missed  -23.3
 Jun. 30 2021  -0.04       -0.04      -0.11     Missed  -181
 This summary was machine generated July 29 at 00:31 GMT.  All
figures in US dollars  unless otherwise stated